Seeking Alpha

Jazz Pharmaceuticals (JAZZ) is halted after the company announces it will merge with Ireland's...

Jazz Pharmaceuticals (JAZZ) is halted after the company announces it will merge with Ireland's Azur Pharma in an all-stock deal. Like Jazz, Azur develops drugs for treating women's health and central nervous system issues. The combined company will have $475M+ in revenue and $200M+ in cash flow in its first 12 months.
Comments (1)
  • thesuer
    , contributor
    Comments (258) | Send Message
     
    SELL Jazz buy VRTX
    18 Jan 2012, 08:51 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector